| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/18/2008 | WO2008152654A1 Anthrax fusion proteins, compositions and uses thereof |
| 12/18/2008 | WO2008152537A2 Humanized monoclonal antibodies |
| 12/18/2008 | WO2008152447A2 Staphylococcus aureus specific anti-infectives |
| 12/18/2008 | WO2008152429A1 Chemically modified peptides with improved immunogenicity |
| 12/18/2008 | WO2008152262A2 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 12/18/2008 | WO2008152252A2 Rumc peptides with antimicrobial activity |
| 12/18/2008 | WO2008152067A1 An allergen dosage form comprising an antihistamine |
| 12/18/2008 | WO2008152052A1 Intradermal influenza vaccine |
| 12/18/2008 | WO2008151808A1 Diagnostic method |
| 12/18/2008 | WO2008151637A2 Neuroplastin derived peptides |
| 12/18/2008 | WO2008151449A1 Method for the treatment of atopic eczema |
| 12/18/2008 | WO2008151389A1 Chemically modified macromolecules |
| 12/18/2008 | WO2008134643A3 Trypanosoma antigens, vaccine compositions, and related methods |
| 12/18/2008 | WO2008131406A3 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5 |
| 12/18/2008 | WO2008131315A3 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 12/18/2008 | WO2008131298A3 Prevention and treatment of cerebral amyloid angiopathy |
| 12/18/2008 | WO2008130969A3 Novel compounds |
| 12/18/2008 | WO2008128065A3 Tuberculosis vaccine and method of using same |
| 12/18/2008 | WO2008127840A9 Flavivirus ns5a proteins for the treatment of hiv |
| 12/18/2008 | WO2008127279A3 Methods for treating, preventing and diagnosing porcine ttv infection |
| 12/18/2008 | WO2008118861A3 Discrete size and shape specific organic nanoparticles designed to elicit an immune response |
| 12/18/2008 | WO2008118691A3 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/18/2008 | WO2008110771A3 Composition comprising an il-8 blocking agent and/or a trail blocking agent for use in the treatment of liver disease and hepatic flares |
| 12/18/2008 | WO2008109833A3 Polynucleotides and polypeptides identified by iviat screening and methods of use |
| 12/18/2008 | WO2008100563A3 Compositions and methods for diagnosing and treating cancer |
| 12/18/2008 | WO2008094942A3 Humanized antibodies against cxcr3 |
| 12/18/2008 | WO2008094510A3 Methods of modulating immune function |
| 12/18/2008 | WO2008094370A3 Method of detecting ocular diseases and pathologic conditions and treatment of same |
| 12/18/2008 | WO2008091911A8 Use of antibody conjugates |
| 12/18/2008 | WO2008085938A8 Antibody inhibiting infection of papillomavirus |
| 12/18/2008 | WO2008085147A3 Novel plant virus particles and methods of inactivation thereof |
| 12/18/2008 | WO2008083174A3 Compositions and methods for the treatment of infections and tumors |
| 12/18/2008 | WO2008076490A3 Histophilus somni antigens, compositions and methods of use |
| 12/18/2008 | WO2008076371A3 Method for replicating influenza virus in culture |
| 12/18/2008 | WO2008073312B1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 12/18/2008 | WO2008060634A3 Human complement c3 derivatives with cobra venom factor-like function |
| 12/18/2008 | WO2008049056A3 Treatment of medical condition with a2 domain of von willebrand factor |
| 12/18/2008 | WO2008045286A3 Preparation of inactivated artificial antigen presenting cells and their use in cell therapies |
| 12/18/2008 | WO2008043072A3 Cd80 antagonists for treating neoplastic disorders |
| 12/18/2008 | WO2008027236A3 Multispecific antibodies |
| 12/18/2008 | WO2008027099A3 Rpa optimization |
| 12/18/2008 | WO2008006106A3 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 12/18/2008 | WO2007146857A8 Anti- mcp-1 antibodies expressed in lemna, compositions, methods and uses |
| 12/18/2008 | WO2007142667A3 Treatment of patients with autoantibody positive disease |
| 12/18/2008 | WO2007130535A3 Novel protein fusion/tag technology |
| 12/18/2008 | WO2007109742A3 Methods for humanizing antibodies and humanized antibodies made thereby |
| 12/18/2008 | WO2007097820A3 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 12/18/2008 | WO2007095345A3 Methods and compositions for regulation of neurological conditions |
| 12/18/2008 | WO2007095308A3 Compositions and methods to promote neural cell growth |
| 12/18/2008 | WO2007089601A9 Nogo receptor antagonists |
| 12/18/2008 | WO2007075706A3 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
| 12/18/2008 | WO2006125076A8 Methods and compositions for immunizing against chlamydia infection |
| 12/18/2008 | WO2006102170A3 Recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 12/18/2008 | US20080312421 Use of A33 antigens and JAM-it |
| 12/18/2008 | US20080312412 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines |
| 12/18/2008 | US20080312172 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 12/18/2008 | US20080312158 Semaphorin Gene Family |
| 12/18/2008 | US20080312137 Fed Batch Culture Methods for Streptococci |
| 12/18/2008 | US20080312135 Mixtures of drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 12/18/2008 | US20080311624 Chimeric immunogens |
| 12/18/2008 | US20080311599 Antibodies against caspase-8, their preparation and use |
| 12/18/2008 | US20080311214 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311182 Multistage delivery of active agents |
| 12/18/2008 | US20080311172 Programmed-release, nanostructured biological construct |
| 12/18/2008 | US20080311159 Methods and Means for Diagnostics, Prevention and Treatment of Mycobacterium Infections and Tuberculosis Disease |
| 12/18/2008 | US20080311158 Hepatitis C Virus Replication System |
| 12/18/2008 | US20080311157 Pharmaceutical Compound Capable of Induce Immune Protective Response Against Dengue Virus Having the Capsid Protein of the Dengue Virus |
| 12/18/2008 | US20080311156 Vaccines |
| 12/18/2008 | US20080311155 Strain-Independent Amplification of Pathogens and Vaccines Thereto |
| 12/18/2008 | US20080311154 Cold-adapted equine influenza viruses |
| 12/18/2008 | US20080311153 prepared by mating isolated strains; for prevention of seasonal and sudden outbreaks |
| 12/18/2008 | US20080311152 Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer |
| 12/18/2008 | US20080311151 Vaccine For Periodontal Disease |
| 12/18/2008 | US20080311150 Novel sequences encoding hepatitis C virus glycoproteins |
| 12/18/2008 | US20080311149 DNA-transfection system for the generation of infectious influenza virus |
| 12/18/2008 | US20080311148 DNA-transfection system for the generation of infectious influenza virus |
| 12/18/2008 | US20080311147 Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens |
| 12/18/2008 | US20080311146 Immunogenic Composition |
| 12/18/2008 | US20080311145 Protein cage immunotherapeutics |
| 12/18/2008 | US20080311144 Mutant forms of cholera holotoxin as an adjuvant |
| 12/18/2008 | US20080311143 Porcine reproductive respiratory syndrome virus (PRRSV); replicons |
| 12/18/2008 | US20080311142 Cancer vaccines and vaccination methods |
| 12/18/2008 | US20080311141 Cancer vaccines and vaccination methods |
| 12/18/2008 | US20080311140 Antigen specific immunosuppression by dendritic cell therapy |
| 12/18/2008 | US20080311139 Plant Produced Vaccine for Amebiasis |
| 12/18/2008 | US20080311138 Adjuvant Activity of Gastrointestinal Peptides |
| 12/18/2008 | US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof |
| 12/18/2008 | US20080311135 Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations |
| 12/18/2008 | US20080311134 engineered by replacing one or more amino acids of a parent anti-MUC16 antibody with non cross-linked, reactive cysteine amino acids; Cys engineered anti-MUC16 antibodies (Ab) containing a heavy chain sequence, conjugated with one or more drug moieties through a linker; diagnostic and therapeutic uses |
| 12/18/2008 | US20080311133 Methods of using multivalent mhc class ii-peptide chimeras |
| 12/18/2008 | US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function |
| 12/18/2008 | US20080311131 Human Mob-5 (IL-24) receptors and uses thereof |
| 12/18/2008 | US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity |
| 12/18/2008 | US20080311129 Adherence inhibitor directed to and method of making and using |
| 12/18/2008 | US20080311128 Method for Treating Pathological Pulmonary Conditions and Bleomycin Associated Pulmonary Fibrosis |
| 12/18/2008 | US20080311127 Combination therapy for treating disease |
| 12/18/2008 | US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer |
| 12/18/2008 | US20080311125 Scytovirin Domain 1 Related Polypeptides |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |